authID (AUID) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 05, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	authID Inc.
Entity Central Index Key	0001534154
Entity File Number	001-40747
Entity Tax Identification Number	46-2069547
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	1580 North Logan Street
Entity Address, Address Line Two	Suite 660, Unit 51767
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80203
Entity Phone Fax Numbers [Line Items]
City Area Code	516
Local Phone Number	274-8700
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock par value $0.0001 per share
Trading Symbol	AUID
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		10,920,909

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets:
Cash	$ 11,718,392	$ 10,177,099
Accounts receivable, net	223,606	91,277
Deferred contract costs	102,167	157,300
Other current assets, net	686,382	476,004
Contract assets	342,544
Total current assets	13,073,091	10,901,680
Intangible assets, net	213,373	327,001
Goodwill	4,183,232	4,183,232
Total assets	17,469,696	15,411,913
Current Liabilities:
Accounts payable and accrued expenses	984,397	1,408,965
Deferred revenue	329,343	131,628
Commission liability		124,150
Accrued severance liability	325,000
Convertible debt, net	236,769
Total current liabilities	1,875,509	1,664,743
Non-current Liabilities:
Convertible debt, net		224,424
Accrued severance liability		325,000
Total liabilities	1,875,509	2,214,167
Commitments and Contingencies (Note 7)
Stockholders’ Equity:
Common stock, $0.0001 par value, 150,000,000 and 250,000,000 shares authorized; 10,920,909 and 9,450,220 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	1,092	945
Additional paid-in capital	184,800,174	172,714,712
Accumulated deficit	(169,214,154)	(159,530,535)
Accumulated comprehensive income	7,075	12,624
Total stockholders’ equity	15,594,187	13,197,746
Total liabilities and stockholders’ equity	$ 17,469,696	$ 15,411,913

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	150,000,000	250,000,000
Common stock, shares issued	10,920,909	9,450,220
Common stock, shares outstanding	10,920,909	9,450,220

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues, net	$ 248,920	$ 43,389	$ 686,736	$ 118,387
Operating Expenses:
General and administrative	2,102,549	3,013,554	6,334,070	5,853,218
Research and development	1,615,970	701,495	4,213,041	1,525,723
Depreciation and amortization	43,798	60,416	131,210	212,450
Total operating expenses	3,762,317	3,775,465	10,678,321	7,591,391
Loss from continuing operations	(3,513,397)	(3,732,076)	(9,991,585)	(7,473,004)
Other Income (Expense):
Interest expense	(12,712)	(13,138)	(36,219)	(1,095,320)
Interest income	161,308	29,511	344,185	30,671
Loss on debt extinguishment				(380,741)
Conversion expense				(7,476,000)
Other income (expense), net	148,596	16,373	307,966	(8,921,390)
Loss from continuing operations before income taxes	(3,364,801)	(3,715,703)	(9,683,619)	(16,394,394)
Income tax expense				(3,255)
Loss from continuing operations	(3,364,801)	(3,715,703)	(9,683,619)	(16,397,649)
Gain (loss) from discontinued operations		(1,915)		1,524
Gain on sale of discontinued operations				216,069
Total gain (loss) from discontinued operations		(1,915)		217,593
Net loss	$ (3,364,801)	$ (3,717,618)	$ (9,683,619)	$ (16,180,056)
Earnings (Loss) Per Share - Basic and Diluted
Continuing operations, Basic (in Dollars per share)	$ (0.31)	$ (0.47)	$ (0.97)	$ (3.05)
Continuing operations, Diluted (in Dollars per share)	(0.31)	(0.47)	(0.97)	(3.05)
Discontinued operations, Basic (in Dollars per share)		0		0.04
Discontinued operations, Diluted (in Dollars per share)		$ 0		$ 0.04
Weighted Average Shares Outstanding - Basic (in Shares)	10,920,872	7,874,962	9,961,110	5,376,821
Weighted Average Shares Outstanding – Diluted (in Shares)	10,920,872	7,874,962	9,961,110	5,376,821

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net Loss	$ (3,364,801)	$ (3,717,618)	$ (9,683,619)	$ (16,180,056)
Foreign currency translation gain (loss)	967	12,592	(5,549)	(143,545)
Comprehensive loss	$ (3,363,834)	$ (3,705,026)	$ (9,689,168)	$ (16,323,601)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance at Dec. 31, 2022	$ 318	$ 140,257,448	$ (140,130,159)	$ 155,929	$ 283,536
Balance (in Shares) at Dec. 31, 2022	3,179,789
Stock-based compensation		(22,949)			(22,949)
Warrants issued for services		438,000			438,000
Shares issued in lieu of interest	$ 11	387,567			387,578
Shares issued in lieu of interest (in Shares)	111,516
Conversion of convertible notes into common stock	$ 235	15,331,775			15,332,010
Conversion of convertible notes into common stock (in Shares)	2,348,347
Conversion of credit facility borrowings into common stock	$ 24	899,976			900,000
Conversion of credit facility borrowings into common stock (in Shares)	245,634
Sale of common stock for cash, net of offering costs	$ 198	6,321,294			6,321,492
Sale of common stock for cash, net of offering costs (in Shares)	1,989,676
Net loss			(16,180,056)		(16,180,056)
Foreign currency translation				(143,545)	(143,545)
Balance at Sep. 30, 2023	$ 786	163,613,111	(156,310,215)	12,384	7,316,066
Balance (in Shares) at Sep. 30, 2023	7,874,962
Balance at Jun. 30, 2023	$ 786	162,155,308	(152,592,597)	(208)	9,563,289
Balance (in Shares) at Jun. 30, 2023	7,874,962
Stock-based compensation		1,519,952			1,519,952
Incremental offering costs		(62,149)			(62,149)
Net loss			(3,717,618)		(3,717,618)
Foreign currency translation				12,592	12,592
Balance at Sep. 30, 2023	$ 786	163,613,111	(156,310,215)	12,384	7,316,066
Balance (in Shares) at Sep. 30, 2023	7,874,962
Balance at Dec. 31, 2023	$ 945	172,714,712	(159,530,535)	12,624	$ 13,197,746
Balance (in Shares) at Dec. 31, 2023	9,450,220				9,450,220
Stock-based compensation		2,044,210			$ 2,044,210
Conversion of credit facility borrowings into common stock
Sale of common stock for cash, net of offering costs	$ 146	10,041,253			10,041,399
Sale of common stock for cash, net of offering costs (in Shares)	1,464,965
Cashless stock option exercise	$ 1	(1)
Cashless stock option exercise (in Shares)	5,724
Net loss			(9,683,619)		(9,683,619)
Foreign currency translation				(5,549)	(5,549)
Balance at Sep. 30, 2024	$ 1,092	184,800,174	(169,214,154)	7,075	$ 15,594,187
Balance (in Shares) at Sep. 30, 2024	10,920,909				10,920,909
Balance at Jun. 30, 2024	$ 1,092	184,164,638	(165,849,353)	6,108	$ 18,322,485
Balance (in Shares) at Jun. 30, 2024	10,920,851
Stock-based compensation		595,536			595,536
Reclass of offering costs		40,000			40,000
Cashless stock option exercise
Cashless stock option exercise (in Shares)	58
Net loss			(3,364,801)		(3,364,801)
Foreign currency translation				967	967
Balance at Sep. 30, 2024	$ 1,092	$ 184,800,174	$ (169,214,154)	$ 7,075	$ 15,594,187
Balance (in Shares) at Sep. 30, 2024	10,920,909				10,920,909

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (9,683,619)	$ (16,180,056)
Adjustments to reconcile net loss with cash flows from operations:
Stock-based compensation	2,044,210	(22,949)
Depreciation and amortization expense	131,210	212,450
Provision for doubtful collection of other receivable		150,000
Amortization of debt discounts and issuance costs	12,345	693,420
Non-cash recruiting fees		438,000
Shares issued in lieu of interest		387,578
Gain from sale of discontinued operation		(216,069)
Loss on debt extinguishment		380,741
Conversion expense		7,476,000
Changes in operating assets and liabilities:
Accounts receivable	(132,329)	212,977
Deferred contract costs	(69,017)	(66,300)
Other current assets	(552,922)	66,676
Accounts payable and accrued expenses	(424,961)	(178,428)
Deferred revenue	197,715	21,734
Other accrued liabilities		290,000
Adjustments relating to discontinued operations		110,064
Net cash flows from operating activities	(8,477,368)	(6,224,162)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of discontinued operations, net of selling costs		91,751
Purchase of intangible assets	(17,582)	(16,601)
Net cash flows from investing activities	(17,582)	75,150
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net of offering costs	10,041,399	6,321,492
Credit facility drawdown, net of issuance costs		543,760
Net cash flows from financing activities	10,041,399	6,865,251
Effect of Foreign Currencies	(5,156)	(145,035)
Net Change in Cash	1,541,293	571,204
Cash, Beginning of the Period	10,177,099	3,237,106
Cash, Beginning of the Period - Discontinued Operations		2,703
Cash, End of the Period - Discontinued Operations
Cash, End of the Period	11,718,392	3,811,014
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	23,873
Cash paid for income taxes - discontinued operations		364
Cash paid for income taxes		3,255
Cash paid for income taxes - discontinued operations		1,254
Schedule of Non-cash Investing and Financing Activities:
Conversion of convertible note payable and accrued interest to common stock		7,856,011
Conversion of credit facility borrowings into common stock		900,000
Warrants for services with the sale of common stock	877,392	725,889
Cashless option and warrant exercises	$ 1

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2024
Basis of Presentation [Abstract]
BASIS OF PRESENTATION	NOTE 1 – BASIS OF PRESENTATION In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year. The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. Going Concern As of September 30, 2024, the Company had an accumulated deficit of approximately $169.2 million. For the three and nine months ended September 30, 2024, the Company earned revenue from continuing operations of approximately $0.25 million and $0.69 million, used approximately $2.7 million and $8.5 million to fund its operations, and incurred a net loss of approximately $3.4 million and $9.7 million. The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms. There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern. Reclassification Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and nine months ended September 30, 2023, we reclassified approximately $48,000 and $141,000, respectively, in expenses from research and development expenses to general and administrative expenses. Net Loss per Common Share The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2024 and 2023 because their effect was antidilutive: Security 2024 2023 Convertible notes payable 8,277 8,277 Warrants 697,446 488,018 Stock options 1,991,048 1,685,570 2,696,771 2,181,865 Revenue Recognition Software License For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue. The company accounts for any price concessions granted to a customer as reductions to consideration under each respective contract and subsequently recognizes revenue up to the amount of the revised consideration after the concession is provided. Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period. The Company had deferred revenue contract liabilities of approximately $329,000 and $132,000 as of September 30, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. Concentration of Revenue and Accounts Receivable For the nine months ended September 30, 2024, two customers represented 64% of revenue. For the nine months ended September 30, 2023, one customer represented 49% of revenue. For the three months ended September 30, 2024, three customers represented 84% of revenue. For the three months ended September 30, 2023, one customer represented 53% of revenue. As of September 30, 2024, three customers accounted for 71%, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, of accounts receivable. Remaining Performance Obligations As of September 30, 2024, the Company’s Remaining Performance Obligation (RPO) was $3.83 million, of which $0.33 million is recorded as deferred revenue and $3.50 million is related to other non-cancellable contracted amounts. The Company expects approximately 27% of the RPO to be recognized as revenue over the twelve months ending September 30, 2025, based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties. In July 2024, the Company evaluated the rollout timelines for several customers who have delayed go-live adoption dates due to their respective corporate processes and timelines. The Company expects to amend an agreement with certain customers (who comprises $1.4 million of the Company’s RPO as of September 30, 2024) to modify the terms of their contract and defer the timing of their minimum payment obligations. The Company expects these modification agreements to be finalized during the quarter ending December 31, 2024, resulting in a reduction in the future periodic recognition of the revenue associated with this performance obligation through the end of the modified contract period, December 31, 2027. The proposed modifications are not expected to affect the overall RPO associated with the customer contracts. Deferred Contract Costs Deferred Contract Carrying Value at December 31, 2023 $ 157,300 Additions 32,572 Reversals (71,500 ) Amortization (16,205 ) Carrying Value at September 30, 2024 $ 102,167

Other Current Assets

Other Current Assets	9 Months Ended
	Sep. 30, 2024
Other Current Assets [Abstract]
OTHER CURRENT ASSETS	NOTE 2 – OTHER CURRENT ASSETS Other current assets consisted of the following at September 30, 2024 (unaudited) and December 31, 2023: September 30, December 31, 2024 2023 Prepaid insurance $ 225,604 $ 184,492 Prepaid third-party and related party services 460,778 291,512 $ 686,382 $ 476,004

Intangible Assets, Net (Other t

Intangible Assets, Net (Other than Goodwill)	9 Months Ended
	Sep. 30, 2024
Intangible Assets, Net (Other than Goodwill) [Abstract]
INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)	NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL) The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the nine months ended September 30, 2024 (unaudited): Acquired and Developed Software Patents Total Useful Lives 5 Years 10 Years Carrying Value at December 31, 2023 $ 212,798 $ 114,203 $ 327,001 Additions - 17,582 17,582 Amortization (117,878 ) (13,332 ) (131,210 ) Carrying Value at September 30, 2024 $ 94,920 $ 118,453 $ 213,373 The following is a summary of intangible assets as of September 30, 2024 (unaudited): Acquired and Developed Software Patents Total Cost $ 1,734,662 $ 182,196 $ 1,916,858 Accumulated amortization (1,639,742 ) (63,743 ) (1,703,485 ) Carrying Value at September 30, 2024 $ 94,920 $ 118,453 $ 213,373 Amortization expense totaled approximately $131,000 and $212,000 for the nine months ended September 30, 2024, and 2023, respectively. Future expected amortization of intangible assets is as follows: 2024 (Remainder of the Year) $ 43,847 2025 71,089 2026 20,986 2027 18,219 2028 18,219 Thereafter 41,013 $ 213,373 There were no impairment indicators noted with respect to the Company’s long-lived assets, including intangible assets, as of September 30, 2024.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	9 Months Ended
	Sep. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consisted of the following as of September 30, 2024 (unaudited) and December 31, 2023: September 30, December 31, 2024 2023 Trade payables $ 347,762 $ 235,606 Accrued payroll and related obligations 202,730 707,317 Insurance Premium Liability 163,696 104,226 Other accrued expenses 270,209 361,816 $ 984,397 $ 1,408,965

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS Board of Directors On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the board of directors of the Company (the “Board”) accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin on June 28, 2023, amounting to 6,511 shares. On March 25, 2024, Mr. Kunal Mehta was appointed as a Director of the Company, upon the standard terms for non-employee Directors. On May 20, 2024, Mr. Mehta was granted an option to purchase 13,282 shares of common stock at an exercise price of $7.78 per share. 12,500 of the shares vest annually in equal amounts over a three-year period commencing in 2025 and 782 shares vested monthly in equal amounts over a three-month period commencing March 2024. On August 13, 2024, the Company granted 15,627 options each at the exercise price of $8.67 per share to Messrs. Michael Koehneman, Michael Thompson, Ken Jisser, Kunal Mehta and Ms. Jacqueline White, in accordance with the Company’s compensation policy for non-employee directors. Each such option vests over a period of twelve months. Commercial Agreements On June 6, 2023, the Company entered into a services agreement with The Pipeline Group, Inc. (“TPG”). Ken Jisser, a director of the Company, is the founder and CEO of TPG, a technology-enabled services company that aims to deliver business results for companies looking to build a predictable and profitable pipeline. As of September 30, 2024, the Company held a balance of approximately $117,000 in prepaid expenses related to this service agreement. In June 2024, the agreement with TPG was renewed for an additional year at a reduced fee rate of $70,000 per month. Total expense incurred under this contract during the three and nine months ended September 30, 2024 was approximately $210,000 and $752,000, respectively. Total expense incurred under this contract during the three and nine months ended September 30, 2023 was approximately $141,000 and $260,000, respectively. Employment Agreement Since June 2023, the Company has employed Dale Daguro, the brother of our CEO, Rhon Daguro as a VP Sales. Dale Daguro’s employment is at will and may be terminated at any time, with or without cause. Dale’s compensation is commensurate with other executives employed by the Company at a similar level of seniority and experience. During the nine months ended September 30, 2024, Dale Daguro earned approximately $201,000 in base salary and sales commission. Issuance of Common Stock On June 27, 2024, Michael Thompson, a Director of the Company purchased 12,254 shares of the Company’s common stock at an aggregate price of $100,000, as part of the Company’s Registered Direct offering (See Note 6 – Stockholders’ Equity).

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2024
Stockholders' Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 6 STOCKHOLDERS’ EQUITY Common Stock On June 27, 2024, pursuant to Securities Purchase Agreements in a Registered Direct Offering, the Company issued 1,464,965 shares of common stock for cash gross proceeds of approximately $11.0 million (or approximately $10.0 million, net of offering costs). During the nine months ended September 30, 2024 the Company issued 5,724 shares of common stock, upon the cashless exercise of stock options. During the nine months ended September 30, 2023, shares of common stock were issued as a result of the following transactions: ● On May 26, 2023, pursuant to Securities Purchase Agreements, the Company issued 1,989,676 shares of common stock for cash gross proceeds of approximately $7.3 million (or approximately $6.4 million, net of offering costs). ● On May 26, 2023, pursuant to a Securities Purchase Agreement, Mr. Garchik capitalized the outstanding principal balance of $900,000 under the Initial Promissory Note, into 245,634 shares of common stock. ● On May 26, 2023, pursuant to an exchange agreement with Holders of Convertible Notes payable, the Company issued 2,348,347 shares of common stock in exchange for Convertible Notes in the gross principal amount of approximately $8.9 million (approximately $7.9 million, net of debt issuance costs and discount). In addition, the Company recorded approximately $7.5 million of expense on conversion of convertible notes. ● The Company issued 111,516 shares of common stock for approximately $388,000 of interest accrued under the Convertible Notes and Credit Facility. Warrants On June 27, 2024, in connection with their placement agent services, the Company issued 102,547 common stock warrants to the placement agent, with a term of 5 years and an exercise price of $7.50 per share. During the nine months ended September 30, 2023, warrants were issued as a result of the following transactions: ● On May 26, 2023, in connection with their placement agent services, the Company issued 156,712 common stock warrants to the placement agent, with a term of 5 years and an exercise price of $3.664 per share. ● On May 12, 2023, in connection with certain recruitment services, the Company issued 187,500 common stock warrants to the placement agent with a term of 5 years and an exercise price of $3.164 per share. The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2024 (unaudited): Weighted Weighted Average Average Number of Exercise Remaining Shares Price Life Outstanding, December 31, 2023 598,267 $ 11.89 3.9 Years Granted 102,547 $ 7.50 4.8 Years Exercised/Cancelled (3,368 ) $ 21.12 - Outstanding, September 30, 2024 697,446 $ 11.20 3.6 Years Stock Options During the nine months ended September 30, 2024, ● The Company granted directors a total of 91,417 options at exercise prices ranging from $7.78 to $8.67 per share. ● The Company also granted 220,000 options to certain new employees at exercise prices ranging from $7.99 to $9.61 per share. ● The Company agreed to accelerate the vesting of 6,511 options for Mr. Joe Trelin under the terms of his resignation with an exercise price of $5.48 per share. These accelerated options would not otherwise have vested prior to termination of service according to their Service conditions. Therefore, the Company recalculated the fair value of these options as of his resignation date of February 20, 2024 using the Black Scholes method. ● Certain stock option holders exercised their stock options and were issued approximately 5,724 shares of our common stock. The Company determined the grant date fair value of options granted for the nine months ended September 30, 2024, using the Black Scholes Method, as applicable, with the following assumptions: Expected volatility 118 – 123% Expected term 5 years Risk free rate 3.49% - 4.46% Dividend rate 0.00% Activity related to stock options for the nine months ended September 30, 2024 (unaudited), is summarized as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 1,796,743 $ 25.20 6.5 $ 3,630,733 Granted 311,417 $ 8.69 10.0 $ - Exercised (15,875 ) $ 5.49 - $ - Forfeited/cancelled (101,237 ) $ 39.04 7.0 $ - Outstanding as of September 30, 2024 1,991,048 $ 22.07 6.3 $ 1,314,090 Exercisable as of September 30, 2024 1,184,263 $ 28.67 4.7 $ 735,615 The following table summarizes stock option information as of September 30, 2024 (unaudited): Weighted Average Contractual Exercise Price Outstanding Term (Yrs.) Exercisable $2.64 – $5.00 344,379 8.5 193,339 $5.01 – $10.00 828,272 9.1 257,490 $10.01 – $15.00 43,078 2.1 43,078 $15.01 – $20.00 252,084 1.0 252,084 $20.01 – $121.28 523,235 3.3 438,272 1,991,048 6.3 1,184,263 During the nine months ended September 30, 2024, the Company recognized approximately $2.1 million of stock option-based compensation expense. As of September 30, 2024, there was approximately $2.6 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2027. On May 24, 2024, the Board of Directors adopted the 2024 Equity Incentive Plan (the “2024 Plan”). On June 26, 2024, the stockholders approved and ratified the 2024 Plan and the allocation of 395,000 shares of Common Stock to the 2024 Plan, in addition to the remaining shares not allocated to awards under the 2021 Equity Incentive Plan and any shares, which become available as a result of the forfeiture, or cancellation of any previous awards. As of September 30, 2024, there were 447,523 shares allocated to and available for issuance of awards under the 2024 Plan. During the nine months ended September 30, 2024, the Company also issued 140,000 options to purchase common stock and agreed to grant 100,000 options to newly hired employees as inducement grants under Nasdaq Listing Rule 5635(c)(4), which are not included in the totals for the 2024 Plan.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (3,364,801)	$ (3,717,618)	$ (9,683,619)	$ (16,180,056)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2024
Basis of Presentation [Abstract]
Going Concern	Going Concern As of September 30, 2024, the Company had an accumulated deficit of approximately $169.2 million. For the three and nine months ended September 30, 2024, the Company earned revenue from continuing operations of approximately $0.25 million and $0.69 million, used approximately $2.7 million and $8.5 million to fund its operations, and incurred a net loss of approximately $3.4 million and $9.7 million. The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms. There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.
Reclassification	Reclassification Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and nine months ended September 30, 2023, we reclassified approximately $48,000 and $141,000, respectively, in expenses from research and development expenses to general and administrative expenses.
Net Loss per Common Share	Net Loss per Common Share The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2024 and 2023 because their effect was antidilutive: Security 2024 2023 Convertible notes payable 8,277 8,277 Warrants 697,446 488,018 Stock options 1,991,048 1,685,570 2,696,771 2,181,865
Revenue Recognition	Revenue Recognition Software License For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue. The company accounts for any price concessions granted to a customer as reductions to consideration under each respective contract and subsequently recognizes revenue up to the amount of the revised consideration after the concession is provided. Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period. The Company had deferred revenue contract liabilities of approximately $329,000 and $132,000 as of September 30, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods.
Concentration of Revenue and Accounts Receivable	Concentration of Revenue and Accounts Receivable For the nine months ended September 30, 2024, two customers represented 64% of revenue. For the nine months ended September 30, 2023, one customer represented 49% of revenue. For the three months ended September 30, 2024, three customers represented 84% of revenue. For the three months ended September 30, 2023, one customer represented 53% of revenue. As of September 30, 2024, three customers accounted for 71%, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, of accounts receivable.
Remaining Performance Obligations	Remaining Performance Obligations As of September 30, 2024, the Company’s Remaining Performance Obligation (RPO) was $3.83 million, of which $0.33 million is recorded as deferred revenue and $3.50 million is related to other non-cancellable contracted amounts. The Company expects approximately 27% of the RPO to be recognized as revenue over the twelve months ending September 30, 2025, based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties. In July 2024, the Company evaluated the rollout timelines for several customers who have delayed go-live adoption dates due to their respective corporate processes and timelines. The Company expects to amend an agreement with certain customers (who comprises $1.4 million of the Company’s RPO as of September 30, 2024) to modify the terms of their contract and defer the timing of their minimum payment obligations. The Company expects these modification agreements to be finalized during the quarter ending December 31, 2024, resulting in a reduction in the future periodic recognition of the revenue associated with this performance obligation through the end of the modified contract period, December 31, 2027. The proposed modifications are not expected to affect the overall RPO associated with the customer contracts. Deferred Contract Costs Deferred Contract Carrying Value at December 31, 2023 $ 157,300 Additions 32,572 Reversals (71,500 ) Amortization (16,205 ) Carrying Value at September 30, 2024 $ 102,167

Basis of Presentation (Tables)

Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2024
Basis of Presentation [Abstract]
Schedule of Potentially Dilutive Securities	The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and nine months ended September 30, 2024 and 2023 because their effect was antidilutive: Security 2024 2023 Convertible notes payable 8,277 8,277 Warrants 697,446 488,018 Stock options 1,991,048 1,685,570 2,696,771 2,181,865
Schedule of Deferred Contract Cost Activity	The following table summarizes deferred contract cost activity for the nine months ended September 30, 2024: Deferred Contract Carrying Value at December 31, 2023 $ 157,300 Additions 32,572 Reversals (71,500 ) Amortization (16,205 ) Carrying Value at September 30, 2024 $ 102,167

Other Current Assets (Tables)

Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Other Current Assets [Abstract]
Schedule of Other Current Assets	Other current assets consisted of the following at September 30, 2024 (unaudited) and December 31, 2023: September 30, December 31, 2024 2023 Prepaid insurance $ 225,604 $ 184,492 Prepaid third-party and related party services 460,778 291,512 $ 686,382 $ 476,004

Intangible Assets, Net (Other_2

Intangible Assets, Net (Other than Goodwill) (Tables)	9 Months Ended
	Sep. 30, 2024
Intangible Assets, Net (Other than Goodwill) [Abstract]
Schedule of Intangible Assets	The following is a summary of activity related to intangible assets for the nine months ended September 30, 2024 (unaudited): Acquired and Developed Software Patents Total Useful Lives 5 Years 10 Years Carrying Value at December 31, 2023 $ 212,798 $ 114,203 $ 327,001 Additions - 17,582 17,582 Amortization (117,878 ) (13,332 ) (131,210 ) Carrying Value at September 30, 2024 $ 94,920 $ 118,453 $ 213,373 Acquired and Developed Software Patents Total Cost $ 1,734,662 $ 182,196 $ 1,916,858 Accumulated amortization (1,639,742 ) (63,743 ) (1,703,485 ) Carrying Value at September 30, 2024 $ 94,920 $ 118,453 $ 213,373
Schedule of Future Amortization of Intangible Assets	Future expected amortization of intangible assets is as follows: 2024 (Remainder of the Year) $ 43,847 2025 71,089 2026 20,986 2027 18,219 2028 18,219 Thereafter 41,013 $ 213,373

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Accounts payable and accrued expenses consisted of the following as of September 30, 2024 (unaudited) and December 31, 2023: September 30, December 31, 2024 2023 Trade payables $ 347,762 $ 235,606 Accrued payroll and related obligations 202,730 707,317 Insurance Premium Liability 163,696 104,226 Other accrued expenses 270,209 361,816 $ 984,397 $ 1,408,965

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Stockholders' Equity [Abstract]
Schedule of Warrant Activity	The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2024 (unaudited): Weighted Weighted Average Average Number of Exercise Remaining Shares Price Life Outstanding, December 31, 2023 598,267 $ 11.89 3.9 Years Granted 102,547 $ 7.50 4.8 Years Exercised/Cancelled (3,368 ) $ 21.12 - Outstanding, September 30, 2024 697,446 $ 11.20 3.6 Years
Schedule of Grant Date Fair Value of Options Granted	The Company determined the grant date fair value of options granted for the nine months ended September 30, 2024, using the Black Scholes Method, as applicable, with the following assumptions: Expected volatility 118 – 123% Expected term 5 years Risk free rate 3.49% - 4.46% Dividend rate 0.00%
Schedule of Activity Related to Stock Options	Activity related to stock options for the nine months ended September 30, 2024 (unaudited), is summarized as follows: Number Weighted Weighted Aggregate Outstanding at December 31, 2023 1,796,743 $ 25.20 6.5 $ 3,630,733 Granted 311,417 $ 8.69 10.0 $ - Exercised (15,875 ) $ 5.49 - $ - Forfeited/cancelled (101,237 ) $ 39.04 7.0 $ - Outstanding as of September 30, 2024 1,991,048 $ 22.07 6.3 $ 1,314,090 Exercisable as of September 30, 2024 1,184,263 $ 28.67 4.7 $ 735,615
Schedule of Stock Option Information	The following table summarizes stock option information as of September 30, 2024 (unaudited): Weighted Average Contractual Exercise Price Outstanding Term (Yrs.) Exercisable $2.64 – $5.00 344,379 8.5 193,339 $5.01 – $10.00 828,272 9.1 257,490 $10.01 – $15.00 43,078 2.1 43,078 $15.01 – $20.00 252,084 1.0 252,084 $20.01 – $121.28 523,235 3.3 438,272 1,991,048 6.3 1,184,263

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Basis of Presentation [Line Items]
Accumulated deficit	$ (169,214,154)		$ (169,214,154)		$ (159,530,535)
Revenue	250,000		690,000
Net cash used in operations	(2,700,000)		(8,477,368)	$ (6,224,162)
Net loss	(3,364,801)	$ (3,717,618)	(9,683,619)	(16,180,056)
Sale of common stock			10,000,000
Reclassification to general and administrative expenses		$ 48,000		$ 141,000
Deferred revenue contract liabilities	329,000		329,000		132,000
Remaining performance obligation	3,830,000		3,830,000
Deferred revenue	$ 329,343		329,343		$ 131,628
Non cancellable contracted amounts			$ 3,500,000
Percentage of remaining performance obligation	27%		27%
Customer Concentration Risk [Member] | Two Customer [Member] | Revenue Benchmark [Member]
Basis of Presentation [Line Items]
Concentration percentage			64%
Customer Concentration Risk [Member] | Two Customer [Member] | Accounts Receivable [Member]
Basis of Presentation [Line Items]
Concentration percentage					67%
Customer Concentration Risk [Member] | One Customer [Member] | Revenue Benchmark [Member]
Basis of Presentation [Line Items]
Concentration percentage		53%		49%
Customer Concentration Risk [Member] | Three Customer [Member] | Revenue Benchmark [Member]
Basis of Presentation [Line Items]
Concentration percentage	84%
Customer Concentration Risk [Member] | Three Customer [Member] | Accounts Receivable [Member]
Basis of Presentation [Line Items]
Concentration percentage			71%

Basis of Presentation (Detail_2

Basis of Presentation (Details) - Schedule of Potentially Dilutive Securities - shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	2,696,771	2,181,865
Convertible notes payable [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	8,277	8,277
Warrants [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	697,446	488,018
Stock options [Member]
Schedule of Diluted Loss per Share [Line Items]
Total dilutive securities	1,991,048	1,685,570

Basis of Presentation (Detail_3

Basis of Presentation (Details) - Schedule of Deferred Contract Cost Activity	9 Months Ended
	Sep. 30, 2024 USD ($)
Schedule of Deferred Contract Cost Activity [Abstract]
Carrying Value at December 31, 2023	$ 157,300
Additions	32,572
Reversals	(71,500)
Amortization	(16,205)
Carrying Value at September 30, 2024	$ 102,167

Other Current Assets (Details)

Other Current Assets (Details) - Schedule of Other Current Assets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Schedule of Other Current Assets [Abstract]
Prepaid insurance	$ 225,604	$ 184,492
Prepaid third-party and related party services	460,778	291,512
Total other current assets	$ 686,382	$ 476,004

Intangible Assets, Net (Other_3

Intangible Assets, Net (Other than Goodwill) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets [Member]
Intangible Assets, Net (Other than Goodwill) [line Items]
Amortization expense	$ 131,000	$ 212,000

Intangible Assets, Net (Other_4

Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Intangible Assets - USD ($)	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Schedule of Intangible Assets [Line Items]
Carrying Value, Beginning	$ 327,001
Cost	1,916,858
Accumulated amortization	(1,703,485)
Carrying Value at September 30, 2024	213,373	$ 327,001
Additions	17,582
Amortization	(131,210)
Carrying Value, Ending	$ 213,373
Acquired and Developed Software [Member]
Schedule of Intangible Assets [Line Items]
Useful Lives	5 years
Carrying Value, Beginning	$ 212,798
Cost	1,734,662
Accumulated amortization	(1,639,742)
Carrying Value at September 30, 2024	94,920
Additions
Amortization	(117,878)
Carrying Value, Ending	$ 94,920
Patents [Member]
Schedule of Intangible Assets [Line Items]
Useful Lives	10 years
Carrying Value, Beginning	$ 114,203
Cost	182,196
Accumulated amortization	(63,743)
Carrying Value at September 30, 2024	118,453
Additions	17,582
Amortization	(13,332)
Carrying Value, Ending	$ 118,453

Intangible Assets, Net (Other_5

Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Future Amortization of Intangible Assets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Schedule of Future Amortization of Intangible Assets [Abstract]
2024 (Remainder of the Year)	$ 43,847
2025	71,089
2026	20,986
2027	18,219
2028	18,219
Thereafter	41,013
Total	$ 213,373	$ 327,001

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Schedule of Accounts Payable and Accrued Expenses [Abstract]
Trade payables	$ 347,762	$ 235,606
Accrued payroll and related obligations	202,730	707,317
Insurance Premium Liability	163,696	104,226
Other accrued expenses	270,209	361,816
Total	$ 984,397	$ 1,408,965

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)						3 Months Ended			9 Months Ended
	Aug. 13, 2024	Jun. 30, 2024	Jun. 27, 2024	May 20, 2024	Jun. 28, 2023	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Related Party Transactions [Line Items]
Option to purchase shares of common stock (in Shares)			12,254				12,500
Exercise price (in Dollars per share)				$ 7.78
Shares vested (in Shares)							782
Exercise price (in Dollars per share)						$ 28.67			$ 28.67
Vests period	12 months
Prepaid expenses						$ 117,000			$ 117,000
Fee rate		$ 70,000
Total expense						$ 210,000		$ 141,000	752,000	$ 260,000
Salary and sales commission									$ 201,000
Aggregate price			$ 100,000
Messrs [Member]
Related Party Transactions [Line Items]
Shares granted (in Shares)	15,627
Exercise price (in Dollars per share)	$ 8.67
Mr. Trelin [Member]
Related Party Transactions [Line Items]
Unvested option granted (in Shares)					6,511
Mr. Mehta [Member]
Related Party Transactions [Line Items]
Option to purchase shares of common stock (in Shares)				13,282

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)			9 Months Ended
	Jun. 27, 2024	May 26, 2023	Sep. 30, 2024	Sep. 30, 2023	Jun. 26, 2024	Dec. 31, 2023	May 12, 2023
Stockholders’ Equity [Line Items]
Common shares issued			10,920,909			9,450,220
Gross proceeds (in Dollars)	$ 11,000,000	$ 7,300,000	$ 10,041,399	$ 6,321,492
Offering costs (in Dollars)	$ 10,000,000	6,400,000
Exercised shares			15,875
Outstanding principal balance (in Dollars)		$ 900,000
Shares of common stock		245,634
Debt issuance costs and discount (in Dollars)		$ 7,900,000
Expense on conversion of convertible notes (in Dollars)		$ 7,500,000
Granted shares			311,417
Exercise price per share lower (in Dollars per share)			$ 7.78
Exercise price range upper (in Dollars per share)			8.67
Exercise price (in Dollars per share)			$ 8.69
Allocation of shares			447,523		395,000
Warrant [Member]
Stockholders’ Equity [Line Items]
Granted total of stock options	102,547	156,712					187,500
Maturity term of warrant	5 years	5 years					5 years
Warrant exercise price (in Dollars per share)	$ 7.5	$ 3.664					$ 3.164
Convertible Note Payable [Member]
Stockholders’ Equity [Line Items]
Gross principal amount (in Dollars)		$ 8,900,000
Stock Options [Member]
Stockholders’ Equity [Line Items]
Exercised shares			5,724
Granted shares			220,000
Exercise price per share lower (in Dollars per share)			$ 7.99
Exercise price range upper (in Dollars per share)			$ 9.61
Common Stock [Member]
Stockholders’ Equity [Line Items]
Common shares issued	1,464,965
Exercised shares			5,724
Issued shares of common stock		1,989,676	1,464,965	1,989,676
Common stock exchange for Convertible Notes		2,348,347		2,348,347
Convertible notes shares issued			111,516
Interest accrued amount (in Dollars)			$ 388,000
Mr. Kunal Mehta [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			140,000
Mr. Kunal Mehta [Member] | Stock Options [Member]
Stockholders’ Equity [Line Items]
Granted shares			100,000
Stock Options [Member]
Stockholders’ Equity [Line Items]
Stock option based compensation expense (in Dollars)			$ 2,100,000
Unrecognized compensation costs (in Dollars)			$ 2,600,000
Director [Member]
Stockholders’ Equity [Line Items]
Granted shares			91,417
Mr. Joe Trelin [Member] | Stock Options [Member]
Stockholders’ Equity [Line Items]
Accelerate vesting shares			6,511
Exercise price (in Dollars per share)			$ 5.48

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Schedule of Warrant Activity [Line Items]
Number of Shares, Outstanding	598,267	697,446
Weighted Average Exercise Price, Outstanding	$ 11.89	$ 11.2
Weighted Average Remaining Life, Outstanding	3 years 10 months 24 days	3 years 7 months 6 days
Number of Shares, Granted		102,547
Weighted Average Exercise Price, Granted		$ 7.5
Weighted Average Remaining Life, Granted		4 years 9 months 18 days
Number of Shares, Exercised/Cancelled		(3,368)
Weighted Average Exercise Price, Exercised/Cancelled		$ 21.12

Stockholders' Equity (Details_2

Stockholders' Equity (Details) - Schedule of Grant Date Fair Value of Options Granted	9 Months Ended
	Sep. 30, 2024
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Expected term	5 years
Dividend rate	0%
Minimum [Member]
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Expected volatility	118%
Risk free rate	3.49%
Maximum [Member]
Schedule of Grant Date Fair Value of Options Granted [Line Items]
Expected volatility	123%
Risk free rate	4.46%

Stockholders' Equity (Details_3

Stockholders' Equity (Details) - Schedule of Activity Related to Stock Options - USD ($) $ / shares in Units, $ in Millions		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Schedule of Activity Related to Stock Options [Abstract]
Number of Shares, Outstanding	1,796,743	1,991,048
Weighted Average Exercise Price, Outstanding	$ 25.2	$ 22.07
Weighted Average Contractual Term (Yrs.), Outstanding	6 years 6 months	6 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding	$ 3,630,733	$ 1,314,090
Number of Shares, Exercisable		1,184,263
Weighted Average Exercise Price, Exercisable		$ 28.67
Weighted Average Contractual Term (Yrs.), Exercisable		4 years 8 months 12 days
Aggregate Intrinsic Value. Exercisable		$ 735,615
Number of Shares, Granted		311,417
Weighted Average Exercise Price, Granted		$ 8.69
Weighted Average Contractual Term (Yrs.), Granted		10 years
Aggregate Intrinsic Value, Granted
Number of Shares, Exercised		(15,875)
Weighted Average Exercise Price, Exercised		$ 5.49
Weighted Average Contractual Term (Yrs.), Exercised
Aggregate Intrinsic Value, Exercised
Number of Shares, Forfeited/cancelled		(101,237)
Weighted Average Exercise Price, Forfeited/cancelled		$ 39.04
Weighted Average Contractual Term (Yrs.), Forfeited/cancelled		7 years
Aggregate Intrinsic Value, Forfeited/cancelled

Stockholders' Equity (Details_4

Stockholders' Equity (Details) - Schedule of Stock Option Information	9 Months Ended
	Sep. 30, 2024 shares
Schedule of Stock Option Information [Line Items]
Outstanding	1,991,048
Weighted Average Contractual Term (Yrs.)	6 years 3 months 18 days
Exercisable	1,184,263
$2.64 – $5.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	344,379
Weighted Average Contractual Term (Yrs.)	8 years 6 months
Exercisable	193,339
$5.01 – $10.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	828,272
Weighted Average Contractual Term (Yrs.)	9 years 1 month 6 days
Exercisable	257,490
$10.01 – $15.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	43,078
Weighted Average Contractual Term (Yrs.)	2 years 1 month 6 days
Exercisable	43,078
$15.01 – $20.00 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	252,084
Weighted Average Contractual Term (Yrs.)	1 year
Exercisable	252,084
$20.01 – $121.28 [Member]
Schedule of Stock Option Information [Line Items]
Outstanding	523,235
Weighted Average Contractual Term (Yrs.)	3 years 3 months 18 days
Exercisable	438,272